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ABSTRACT
Hypocalcaemia is known for its neuromuscular symptoms, which are rapidly alleviated by intravenous supplementation. Calcium is also 
essential for both cardiac cell excitability and contraction. We present a case of acute heart failure due to hypocalcaemia in a young male 
with a complex medical history.
LEARNING POINTS
• Hypocalcaemia is a rare cause of acute heart failure.
• All clinical decisions, although correct and necessary, may have grave consequences in the short and long term.
•	 Childhood	cancer	survivors	have	an	excess	risk	of	developing	multiple	complications,	namely	heart	failure	and	lung	fibrosis.
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CASE DESCRIPTION
We	present	 the	 case	of	 a	 23-year-old	Caucasian	male	who	was	diagnosed	with	Hodgkin’s	 lymphoma	at	 the	 age	of	 3.	He	first	 received	
chemotherapy with vinblastine, etoposide, bleomycin and prednisone plus radiotherapy, but due to an unsatisfactory response after four 
cycles he was changed to vincristine, prednisone, procarbazine and doxorubicin. He was considered in full remission at the age of 5.
About 10 years later, at a follow-up visit, a new cervical lump was found. The lymph node histology was compatible with thyroid papillary 
carcinoma and staging showed extra-thyroid invasion, with lung and nodal metastasis. Total thyroidectomy with bilateral cervical lymph 
node dissection was performed in 2005, combined with eight cycles of radioiodine from 2005 to 2012. After surgery, he was started on 
levothyroxine, calcium carbonate and calcitriol.
During	follow-up	our	patient	started	complaining	of	mild	exertional	dyspnoea.	Lung	computed	tomography	(CT)	showed	diffuse	lung	fibrosis;	
pulmonary function tests (PFTs) were suggestive of mainly restrictive lung disease. He was then admitted to our heart failure and pulmonary 
hypertension specialty clinic in 2013. At admission he complained of fatigability, dyspnoea at rest and orthopnoea. 
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Echocardiogram estimated a pulmonary artery systolic pressure (PASP) of 60 mmHg, with a markedly dilated right ventricle and mild right 
systolic	dysfunction,	but	preserved	left	systolic	function.	Cardiac	catheterization	confirmed	a	PASP	of	70	mmHg,	a	high	pulmonary	vascular	
resistance index (7.32 Wood units) but no response to stimulation with iloprost. 
A	diagnosis	 of	 pre-capillary	pulmonary	hypertension	 and	 lung	fibrosis	 due	 to	 radiotherapy	 and	 chemotherapy	was	made.	 Symptomatic	
treatment with furosemide 80 mg per day was started and he was discharged.
A few weeks later our patient was re-admitted because of severe worsening of dyspnoea, de novo diplopia and muscle cramps. Physical 
examination showed blood pressure 108/62 mmHg, heart rate 82 beats per minute, and oxygen saturation of 94% with a fraction of inspired 
oxygen of 0.21; rales were audible in the lower halves of both lungs and there was no peripheral oedema. Trousseau’s sign was elicited while 
measuring	blood	pressure.	Arterial	blood	gas	analysis	showed	very	low	ionized	calcium,	confirmed	by	serum	measurements:	0.48	mmol/l	
(normal range: 1.13–1.32 mmol/l). Echocardiogram showed severe systolic cardiac dysfunction, with an estimated ejection fraction of 
16%;	cardiac	magnetic	resonance	(MR)	excluded	constrictive	pericarditis	and	confirmed	global	and	severe	systolic	dysfunction.	A	diagnosis	
of acute heart failure and neuromuscular irritability due to severe hypocalcaemia was made. Intravenous calcium supplementation was 
initiated under close cardiac monitoring. 
Our patient showed an uneventful recovery. At discharge he had mild exertional dyspnoea, serum ionized calcium level was 1.16 mmol/l and 
an echocardiogram showed improved systolic function with an estimated left ventricle ejection fraction of 42%.
DISCUSSION
What is already known
Clinicians are aware of tetany as a hallmark presentation of acute hypocalcaemia. Neuromuscular irritability symptoms – such as muscle 
spasms and cramps, perioral numbness, paraesthesias of hand and feet, clumsiness and, in severe cases, carpopedal spasm and seizures – 
must	be	promptly	recognized	and	addressed.	The	classic	physical	findings	of	this	neuromuscular	irritability	are	Chvostek	and	Trousseau’s	
signs.	Chvostek’s	sign	is	sensitive	but	less	specific,	while	Trousseau’s	sign	is	less	frequent	but	more	specific,	and	implies	more	severe	and	
sustained hypocalcaemia[1].
What is new
Severe hypocalcaemia is a rare but possible cause of acute heart failure. The absolute quantity of ionized calcium that crosses the sarcolemma 
and	 the	 transverse	 tubules	of	 cardiac	 cells	 is	 insufficient	 to	bring	about	 full	 activation	of	 the	 contractile	 apparatus.	Calcium	 influx	 into	
the cardiac cell triggers the release of calcium from the sarcoplasmic reticulum, in a process called calcium-induced calcium release. As a 
consequence, cardiac muscle contraction ensues[2,3]. When hypocalcaemia is present, cardiac performance – estimated by ejection fraction 
– is reduced. All cases of heart failure due to hypocalcaemia published so far demonstrated full systolic dysfunction recovery with calcium 
supplementation [2–4].
Why	is	it	significant
This case illustrates how medical iatrogenesis parallels our practice, no matter how thorough and correct it is. This patient presented with 
acute heart failure due to hypocalcaemia, and we hypothesize that it was precipitated by starting furosemide, since this drug indirectly 
promotes calcium release to the lumen of the ascending loop of Henle. The literature also suggests that the calcium-lowering effect of 
furosemide tends to be greater in the presence of established hypoparathyroidism. 
This patient also serves as an example of how live-saving treatments in childhood often have grave consequences in the long run. In fact, 
Mertens et al. showed that childhood cancer survivors have an all-cause absolute excess risk of 8.8 deaths per 1,000 person-years, which 
is 10.8 times greater than that in general population[5]. The diminished health status and premature death risk seem to derive from both 
disease recurrence and other causes of death, 21.3% of which can be attributed to treatments, such as anthracycline-related heart failure 
and	pulmonary	restrictive	disease	and/or	lung	fibrosis	after	chemotherapy	and	radiotherapy	exposure[5,6]. It is also known that organ damage 
might not be clinically evident until many years later[6]. Consequently, long-term follow-up of childhood cancer survivors is vital to quickly 
detect and address complications and to promote secondary prevention (smoking cessation, weight loss and exercise, for example). Cohort 
studies and case reports also have a role in determining which treatment modalities carry the highest risk and which co-morbidities are to 
be expected[6].
In conclusion, we present a rare cause of acute heart failure in a young patient with a complex medical history. It is also a model case for 
keeping in mind that all medical decisions, even when live-saving, have consequences in the short and long term.
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